About Primity Bio
Primity Bio is a company based in Santa Clara (United States) founded in 2008 by Peter Krutzik was acquired by CellCarta in August 2018. Primity Bio offers products and services including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services. Primity Bio operates in a competitive market with competitors including Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
- Headquarter Santa Clara, United States
- Founders Peter Krutzik
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Primity Bio
Primity Bio offers a comprehensive portfolio of products and services, including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services.
Analyzes clinical biomarkers for drug development applications
Provides digital PCR and RNA sequencing for research
Offers digital pathology and IHC solutions for diagnostics
Conducts assays like FACS for cellular phenotyping
Manages sample handling and biorepository solutions
People of Primity Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Primity Bio
Investors in Primity Bio
Primity Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and CellCarta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Histopathology and genomics services are offered by the CRO.
|
Locked | Locked | Locked |
Investor details for Primity Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Primity Bio
Investment portfolio details for Primity Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Primity Bio
Detailed financials for Primity Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Primity Bio Comparisons
Peer comparison for Primity Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Primity Bio
Primity Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| Locked | Locked | Locked |
Cell and gene therapies for multiple diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a drug pipeline programs for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
AI-based platform for drug discovery and antibody detection is provided.
|
|
| Locked | Locked | Locked |
Protein design, synthesis, testing, and validation services are offered.
|
Detailed competitors of Primity Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Primity Bio
Complete news archive for Primity Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Primity Bio
Primity Bio was founded in 2008.
Primity Bio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Peter Krutzik is the current CEO of Primity Bio. They have also founded this company.
PrimityBio has developed a flowcytometry-based, multiparameter cell analysis system for high content screening with a focus on drug discovery applications. The companys platform performs single cell analysis at more than 10 parameters or markers per cell, at a rate of 5000 cells per second, with sensitivity in the range of 50 molecules per cell. Coupled with automation, the system can screen through 2000 compound wells per day to generate over 100,000 data points. The company also provides the Cytobank flow cytometry software which can analyze the generated data. The systems instrumentation includes a choice of flow cytometers (4, 5 and 6 laser BD LSR II flow cytometers with HTS sample units and up to 19 fluorescent channels, Fluidigm CyTOF Helios Mass Cytometer, BD Aria II Cell Sorter, Agilent VWorks-based automation platform, etc.
Primity Bio offers Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services.